Canada markets close in 56 minutes

LexaGene Holdings Inc. (LXG.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.7700+0.0100 (+1.32%)
As of 2:42PM EST. Market open.

LexaGene Holdings Inc.

500 Cummings Center
Suite 4550
Beverly, MA 01915
United States
800 215 1824
http://www.lexagene.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees32

Key Executives

NameTitlePayExercisedYear Born
Dr. John F. ReganFounder, Chairman & CEO374.84kN/AN/A
Mr. Darrel M. RebeckCo-founder, Pres & Director305.46kN/AN/A
Mr. Jeffrey MitchellCFO, Treasurer & Corp. Sec.284.42kN/AN/A
Mr. Steven ArmstrongVP of OperationsN/AN/AN/A
Mr. Allan John FabbroVP of Corp. Devel.N/AN/A1957
Nicole RidgedaleDirector of Corp. MarketingN/AN/AN/A
Jay AdelaarVP of Capital MarketsN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of automated genetic analyzers for pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company is headquartered in Beverly, Massachusetts.

Corporate Governance

LexaGene Holdings Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.